A subanalysis from the European Randomized study of Screening for Prostate Cancer (ERSPC) showed that participants who failed to attend a prostate cancer screening session despite being invited faced an increased risk of prostate cancer-specific mortality (PCSM).1
The ERSPC included men aged 55 to 69 years.
Conversely, those who did attend a screening session demonstrated a 23% reduced risk of PCSM. The data were presented at the 40th Annual European Association of Urology Congress in Madrid, Spain.
“Our study identifies that men who were invited for screening, but do not attend screening appointments are at significantly higher risk of dying from prostate cancer compared to men who were not offered screening or accepted an invitation for screening,” explained lead author, Renée Leenen MD, a PhD researcher at the…